1.代表论文（#为并列第一作者，*为通讯作者）：
①Hui-ru Cao#, Xin-yun Zhu# , Lin Zhou#, Hua Zhang# , Bin-bin Gu# , Wei Tang #, Jian Ding# ,Jianan Huang# , Xing-hua Shen# , Cheng Chen# ,Bin Cao*.Factors associated with prolonged viral shedding in patients with avian influenza A (H7N9) virus infection[J]. The Journal of infectious diseases, 2018, 217(11): 1708-1717.
②Xing-Hua Shen#,Ping Xu#, Xi Yu#,Hua-Feng Song, Hui Chen,Xue-Guang Zhang,Mei-Ying Wu*, and Xue-Feng Wang*. Discrepant Clinical Significance of CD28+ CD8? and CD4+ CD25high Regulatory T Cells During the Progression of Hepatitis B Virus Infection[J]. Viral Immunology, 2018, 31(8): 548-558.
③Xinghua Shen#, Jianping Zhang, Peijun Tang, Huafeng Song, Xiaocao Liu, Ziyi Huang, Xueguang Zhang, Xuefeng Wang*, Meiying Wu*, Expression and clinical significance of B and T lymphocyte attenuator on CD4+ and CD8+ T cells from patients with pulmonary tuberculosis[J]. Indian Journal ofPathology and Microbiology, 2019, 62(2): 232-238.
④Xin Zhao#, Xiaojuan Chen#, Xinghua Shen#,Peijun Tang# , Chen Chen# ,Qitai Zhu , Muyao Li , Rui Xia , Xi Yang , Chao Feng , Xinguo Zhu , Yibei Zhu ,Zhongwen Sun , Xueguang Zhang, Binfeng Lu * and Xuefeng Wang*. IL-36β Promotes CD8+ T Cell Activation and Antitumor Immune Responses by Activating mTORC1[J], Front Immunology, 2019 Aug 7,10:1803.
⑤Xiaotong Wang#, Zhiqiang Zhou#, Jianping Zhang, Fengfeng Zhu, Yongyan Tang,and Xinghua Shen*.A Case of 2019 Novel Coronavirus in a Pregnant Woman With Preterm Delivery[J] , Clinical Infectious Diseases, 2020 Jul 28,71(15):844-846.
⑥Yantian Lv #, Binbin Gu #, Ying Chen , Siming Hu , Ting Ruan, Guopeng Xu ,Jian Ding b, Xiao Xu *, Xinghua Shen *.No intrauterine vertical transmission in pregnancy with COVID-19: A case report[J].Journal of Infection and Chemotherapy,26 (2020) 1313e1315.
⑦Hui-ru Cao# , Xin-yun Zhu# , Lin Zhou , Hua Zhang , Bin-bin Gu , Wei Tang a, Jian Ding ,Jianan Huang *, Xing-hua Shen *, Cheng Chen *.Factors associated with delayed viral shedding in COVID-19 infectedpatients: A retrospective small-scale study[J]. Respiratory Medicine, 2021 Feb 6,178:106328.
2.主要承担的科研项目：
①江苏省卫健委，重点项目，ZD2022041，共刺激分子在结核病精准诊疗中的作用及应用开发，2023/01-2025/12,主持
②苏州市科技局，苏州市民生科技项目，SS201711，人感染H7N9禽流感疫情防治体系推广与科技示范工程，2017/07-2020/06，主持
③苏州市卫健委科技项目，LCZX201918，结核性脑膜炎诊断流程的研究和推广及脑脊液中抗结核药物代谢与预后的相关性研究，2020/01-2022/12，主持
④苏州市科技局，新型冠状病毒感染应急防治科技专项，SYS2020018，新冠病毒性肺炎重型化临床预警模型及个体化治疗技术的建立，2020/02-2021/01，主持
⑤中国生物技术发展中心，“新型冠状病毒感染的肺炎疫情”应急项目，2020YFC0843700，重症治疗流程和方案优化，2020/03-2021/06，主持
3.获奖情况：
沈兴华(4/9); 菌阴肺结核分子诊断技术及其临床推广应用, 苏州市医学会, 科技进步奖, 2021(吴妹英; 唐佩军; 张建平; 沈兴华; 王霞芳; 冯彦军; 叶志坚; 曾令武; 虞忻 )
4.学术任职：
①中华医学结核病学分会重症专委会 常委
②中国防痨协会学校与儿童结核病专委会 委员
③中国医促会结核病防治分会 委员
④苏州市防痨协会疑难与重症专委会 主委委员
⑤苏州市医学会重症专委会 副主委委员
⑥苏州市医学会结核专委会 副主委委员
5.杂志编委：
《中国防痨杂志》通讯编委